This site is intended for Healthcare Professionals only.

Class 4 medicines defect information issued for Flamingo Pharma’s Ibuprofen 400mg tablets


Share post:

The Medicines and Healthcare products Regulatory Agency has issued a class 4 medicines defect information for Flamingo Pharma’s Ibuprofen 400mg Tablets, EL (22)A/04.

The medicine manufacturer has identified an error relating to the embossed batch number on some cartons of Ibuprofen 400mg tablets.

The batch number is illegible on some cartons and poses a risk to traceability in the event of a future recall or a medical enquiry. The batch numbers on the blisters within the cartons are clear and present.

Additionally, the expiry date is still visible and clearly marked on the carton and blister.

Batch Number Expiry Date Pack Size First Distributed
1403444 12/2025 24 06 September 2021


Advice for pharmacists

The impacted products are within specification and there is no issue with product quality. Therefore, the affected batches are not being recalled.

Healthcare professionals, including community pharmacy teams, should check the blisters before dispensing the affected batch to ensure the batch number can be read.

In the event of a future recall or medical enquiry, the batch number on the blister should be referred to if the number on the carton cannot be read.

A small proportion of these packs have been overlabelled by Mawdsley Brooks & Co Ltd and they have confirmed they will contact customers directly to inform them of this issue.


Please enter your comment!
Please enter your name here

Current Issue December 2023

Related articles

Sanofi Consumer Healthcare signs supply agreements with two wholesalers

Opella Healthcare, trading as Sanofi Consumer Healthcare, said it has entered into a dual partnership agreement with Alliance...

Sigma 2024 Conference: Rishi Sunak sends best wishes to all the participants

The 14th Annual Community Pharmacy Conference by Sigma Pharmaceuticals began on Monday, 25 February at Sun City, South...

Peak Pharmacy branches in Derbyshire and Staffordshire find new owners

‘There is a resurgence in demand for pharmacies that dispense below 4,000 items’ Independent pharmacy chain, Peak Pharmacy, has...

JAS UK granted WDA(H) license for its pharma and healthcare division

Securing the license empowers JAS UK's pharma and healthcare division to seamlessly connect with the company’s more than...